上藥好護(hù)士中藥配方顆粒防治新冠肺炎出口招商項(xiàng)目簡(jiǎn)介

一、企業(yè)簡(jiǎn)介

     遼寧上藥好護(hù)士藥業(yè)（集團(tuán)）有限公司隸屬于世界制藥500 強(qiáng)、中國(guó)第二大制藥集團(tuán)—上海醫(yī)藥股份有限公司，是其控股子a公司，坐落于中國(guó)·遼寧省本溪 市，注冊(cè)資本5000 萬(wàn)元，年銷售8 億元。公司具有100 年中藥制藥歷史，主營(yíng)中藥配方顆粒、中成藥、保健品等。

二、中藥配方顆粒簡(jiǎn)介

    中藥配方顆粒源于傳統(tǒng)中藥飲片，又稱免煎中藥或免煎顆粒，是傳統(tǒng)中藥飲片的升級(jí)換代產(chǎn)品。具有服用方便、作用迅速、療效確切、安全衛(wèi)生、使用方便等許多優(yōu)點(diǎn)。

 在國(guó)內(nèi)各大醫(yī)療機(jī)構(gòu)均有配備使用。本次疫情，中藥配方顆粒在全國(guó)范圍內(nèi)的醫(yī)護(hù)人員和患者中得到了廣泛應(yīng)用，發(fā)揮了重要的防疫、抗疫作用。我公司可長(zhǎng)年大量生產(chǎn)中藥配方顆粒，質(zhì)量?jī)?yōu)良，保障供應(yīng)。

三、項(xiàng)目簡(jiǎn)介

    當(dāng)前新冠肺炎疫情在中國(guó)已經(jīng)得到有效控制，但在世界范圍內(nèi)呈爆發(fā)蔓延趨勢(shì)，在此情況下，公司擬將在此次疫情中發(fā)揮重大作用的中藥配方顆粒產(chǎn)品出口到世界各國(guó)，發(fā)揮抗疫作用。公司將根據(jù)中國(guó)的抗疫經(jīng)驗(yàn)，結(jié)合世界各地的環(huán)境、氣候等因素，重點(diǎn)推出在本次疫情中發(fā)揮重要作用的新冠肺炎預(yù)防一號(hào)方、二號(hào)方、清肺排毒湯等以復(fù)方形式出口，分享給世界，以滿足不同客戶需求，同時(shí)也可以定制加工。具體品種如下：

1、清瘟顆粒（肺炎一號(hào)方）

【處方組成】蒼術(shù)3g，金銀花5g，陳皮3g，蘆根2g，桑葉2g，

黃芪10g

【功能主治】益氣固表、清熱，解毒祛濕。用于新冠肺炎的預(yù)防用藥。

【服用方法】早晚各一次，一次1 袋，開(kāi)水沖服，服7-10 天。

2、肺炎二號(hào)方

【處方組成】黃芪10g、炒白術(shù)10g、防風(fēng)10g、貫眾6g、

金銀花10g、佩蘭10g、陳皮6g。

【功能主治】新冠肺炎預(yù)防用藥。

【服用方法】早晚各一次，一次1 袋，開(kāi)水沖服，服7-10 天。

3、清肺排毒湯：國(guó)家中醫(yī)藥管理局推薦用方（中醫(yī)藥有效方劑篩選研究取得階

段性進(jìn)展，試點(diǎn)省份臨床觀察顯示：清肺排毒湯治療總有效率可達(dá)90%以上。）

【處方組成】香薷15g、炙甘草6g、杏仁9g、生石膏15～30g（先煎）、桂枝9g 、

澤瀉9g、豬苓9g、白術(shù)9g、茯苓15g、柴胡16g、黃芩6g、姜半夏9g、生姜9g、

紫菀9g、冬花9g、射干9g、山藥12g、枳實(shí)6g 、陳皮6g、藿香9g

【功能主治】此方屬于普適型處方，適用于輕型、普通型、重型患者，在危重型

患者救治中可結(jié)合患者實(shí)際情況合理使用。

【用法用量】開(kāi)水沖服，每天一付，早晩各一次（飯后四十分鐘），溫服，三付

一個(gè)療程。

四、招商政策

1、招商區(qū)域：全球范圍內(nèi)尋求合作伙伴，目標(biāo)市場(chǎng)歐洲、美洲、韓

國(guó)、東南亞等國(guó)；

2、招商對(duì)象：具有目標(biāo)區(qū)域豐富中醫(yī)藥推廣資源的公司或個(gè)人；

3、價(jià)格政策：價(jià)格面議；

招商負(fù)責(zé)人：岳金利0086-13190496999

張文濤0086-13942482595

Prevention and Treatment of COVID-19 with  Chinese Herbal Formula

Granules by SPH Liaoning Herbapex Pharmaceutical (Group) Co.,Ltd.

Brief Introduction of Export and Investment  Promotion Project

1. Enterprise Introduction

Liaoning Herbapex Pharmaceutical (Group) Co., Ltd. is affiliated to

the world's top 500 pharmaceutical companies and China's second

largest pharmaceutical group Shanghai Pharmaceuticals Holding

Co.,Ltd.. It is the controlling subsidiary of Shanghai

Pharmaceuticals Holding Co.,Ltd.. Located in Benxi City, Liaoning

Province, China, Liaoning Herbapex has a registered capital of 50

million yuan and annual sales of 800 million yuan. The company

takes pride in its 100-year history in Chinese herbal medicine

industry, and it is mainly engaged in Chinese herbal formula

granules, proprietary Chinese medicine, health products, etc.

2. Introduction of Chinese Herbal Formula Granules

Chinese herbal formula granules originate from traditional Chinese

medicine decoction pieces, also known as decoction-free traditional

Chinese medicine or decoction-free granules, and are upgraded

products of traditional Chinese medicine decoction pieces. This

medicine is easy to take, and its curative effects are rapid and

targeted. Besides, it is risk-free and hygienic. It is equipped for use

in major medical institutions in China. In this epidemic situation,

Chinese medicine formula granules have been widely used by

medical staff and patients nationwide, playing an important role in

epidemic prevention and COVID-19 treatment. Our company can

produce a large number of Chinese medicine formula granules for

a long time, with excellent quality and guaranteed supply.

3. Project Introduction

At present, the COVID-19 epidemic has been effectively controlled

in China, yet the epidemic is breaking out and spreading quickly

across the world. Under such circumstances, our company plans to

export the Chinese herbal formula granules that played an

important role in the epidemic situation control in China to other

countries and help with the fighting against COVID-19. Draw

experience from China's anti-epidemic measures, taken the factors

of environment, climate and race of different regions into

consideration, and learned from anti-epidemic and epidemic

prevention prescriptions of Chinese herbal medicine issued ，

namely COVID-19 Prevention Formula No.1 ， COVID-19

Prevention Formula No.2, and Lung-clearing and Detoxing

Decoction. We hope to export in the form of compound

prescription to meet the needs of different customers. Besides,

customized processing is also available.

Specific varieties are as follows

(1)Inflammation-Eliminating Formula（COVID-19 Prevention Formula No.1

）

[Source of Prescriptions] Hubei Province Diagnosis and Treatment Plan for

COVID-19

[Composition of Prescriptions] Rhizoma Atractylodis 3g; Flos Lonicerae

Japonicae 5g；Pericarpium Citri Reticulatae 3g； Rhizoma Phragmitis 2g；

Folium Mori 2g；Radix Astragali 10g;

[Indications and Usage] Invigorating qi for consolidating superficies, clearing

heat, detoxificating and clearing damp.Prevention of COVID-19.

[Dosage and Administration] One pack per day, mixing it with boiling water.

Drink the decoction twice a day, one in the morning and one in the evening.

Continue this treatment for 7-10 days.

(2) COVID-19 Prevention Formula No.2

[Source of Prescriptions] Hubei Province Diagnosis and Treatment Plan for

COVID-19

[Composition of Prescriptions] Raw astragali radix10g; Roasted atractylodis

macrocephalae rhizome10g; Saposhnikoviae radix10g; Dryopteris

crassirhizomae rhizoma6g; Lonicera japonica flos10g; Eupatorii herba10g;

Citri reticulatae pericarpium6g

[Indications and Usage] Prevention of COVID-19.

[Dosage and Administration] One pack per day, mixing it with boiling water.

Drink the decoction twice a day, one in the morning and one in the evening.

Continue this treatment for 7-10 days.

(3) Lung-clearing and Detoxing Decoction

[Source of Prescriptions] COVID-19 Diagnosis and Treatment Plan (7th Edition

for Trail) issued by National Health Commission of Parties prescription is also

recommended by National Administration of Traditional Chinese Medicine.

(This prescription has achieved phased progress during screening effective

prescriptions of traditional Chinese herbal medicine. Clinical observation in

pilot provinces shows that the total effective rate of Lung-clearing and Detoxing

Decoction was more than 90%.)

[Composition of Prescriptions]Mosla herba15g; Glycyrrhizae radix et rhizoma

praeparata cum melle6g; Armeniacae semen amarum9g; Raw gypsum

fibrosum15-30g(decoct first); Cinnamomi ramulus9g; Alismatis rhizome9g;

Polyporus9g; atractylodis macrocephalae rhizome9g; Poria15g; Bupleuri

radix16g; Scutellariae radix6g; Pinelliae rhizoma praeparatum cum zingibere

et alumine9g; Zingiberis rhizoma recens9g Asteris radix et rhizoma9g; Flos

farfarae9g; Belamcandae rhizoma9g; Dioscoreae rhizom12g; Aurantii fructus

immaturus6g;Citri reticulatae pericarpium6g;Pogostemonis herba9g.

[Indications and Usage] This prescription is universally applicable,

favorable for patients with mild, general and sever symptom. In the

treatment of critically ill patients, it can be adopted according to actual

situation.

[Dosage and Administration] One pack per day, mixing it with boiling water.

Drink the warm decoction twice a day with one in the morning and one in the

morning (40 minutes after meal). Each treatment course included three packs.

4. Investment Promotion Principle

1. Investment promotion area seek partners worldwide, targeting

Europe, America, especially countries in Southeast Asia and South

Korea;

2. Targets of investment promotion companies or individuals with

rich resources for the promotion of traditional Chinese medicine in

the target areas;

3. Price Policy Price negotiable.

Person in charge of investment promotion

Yue Jinli Contact Number0086-13190496999

Zhang Wentao Contact Number0086-13942482595